Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001363399-07-000003
Filing Date
2007-04-13
Accepted
2007-04-13 13:10:07
Documents
1
Period of Report
2007-04-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 12189
  Complete submission text file 0001363399-07-000003.txt   14934
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Issuer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O RMB CAPITAL MANAGEMENT, LLC 10 S. WACKER DR. STE 3210 CHICAGO IL 60606
Business Address C/O RMB CAPITAL MANAGEMENT, LLC 10 S. WACKER DR. STE 3210 CHICAGO IL 60606 312-993-5800
1837 RMB Managers L.L.C. (Reporting) CIK: 0001363399 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50019 | Film No.: 07765259

Mailing Address C/O RMB CAPITAL MANAGEMENT, LLC 10 S. WACKER DR. STE. 3210 CHICAGO IL 60606
Business Address C/O RMB CAPITAL MANAGEMENT, LLC 10 S. WACKER DR. STE. 3210 CHICAGO IL 60606 312-993-5800
1837 Partners QP L.P. (Reporting) CIK: 0001376884 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50019 | Film No.: 07765258